Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)
Closed Posted
- Opportunity number
- PAR-25-157
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Grant
- Category
-
- Health
- Eligible applicants
-
- Higher Education Inst. (Private)
- 501(c)(3) Nonprofits
- Higher Education Inst. (Public)
- Public or Indian Housing Auth.
- Non-501(c)(3) Nonprofits
- Independent School Districts
- County Governments
- Tribal Governments (Federally Recognized)
- Small Businesses
- For Profit Organizations
- Tribal Organizations (Not Federally Recognized)
- Other
- Special District Governments
- State Governments
- City/Township Governments
- Points of contact
-
- NIH OER Webmaster grantsinfo@nih.gov
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Center for Advancing Translational Sciences (NCATS), under the Department of Health and Human Services/National Institutes of Health, is offering the Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) grant (R21 Clinical Trials Not Allowed). This funding opportunity aims to support the early-stage, high-risk, and potentially high-reward development of innovative technologies that can address barriers or limitations in translational science, particularly for therapeutic development. Eligible applicants include higher education institutions, nonprofits, small businesses, and government entities. The focus is on proof-of-concept studies and exploratory technology development that can transform or significantly improve the efficiency of the therapeutic development pipeline.
The grant does not allow clinical trials and falls under CFDA number 93.350. The application deadline is June 18, 2026, and the posted date is December 10, 2024. The funding amount and award size are not specified, but the program seeks to support the development and prototyping of new technologies that can lead to improved efficiency in the therapeutic development process. The research activities are expected to be conducted primarily at the recipient organizations across the United States.
Synopsis
The National Center for Advancing Translational Sciences (NCATS) invites applications for the Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) Notice of Funding Opportunity (NOFO) to foster investigator-initiated development of highly innovative technologies to address barriers, limitations, or bottlenecks in translational science particularly for therapeutic development. This program will support the early-stage proof of concept, high-risk and potentially high-reward studies for feasibility and exploratory technology development, which can transform or significantly improve the efficiency of therapeutic development to achieve NCATS ultimate goals - more treatments to all people more quickly. The research proposed should be for the development of technology that can break new ground or extend present technology toward new directions or novel applications. With this initiative, we expect to support the development and/or prototyping of new technologies that will lead to improved efficiency in the therapeutic development pipeline.
Files
| File | Type | Posted |
|---|---|---|
| PAR-25-157-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity